Lv61
1608 积分 2024-04-28 加入
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
30天前
已完结
The global epidemiology of acute myeloid leukaemia
1个月前
已完结
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
1个月前
已完结
Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
1个月前
已完结
CD276 (B7-H3) Is an Immunotherapeutic Target in Acute Myeloid Leukemia with Preclinical Efficacy of Vobramitamab Duocarmazine, an Investigational CD276 Antibody-Drug Conjugate
1个月前
已关闭
T-cell-engaging bispecific antibodies in cancer
1个月前
已完结
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells]
1个月前
已关闭
MMP9 Serves as a Prognostic Biomarker and Immune‐Associated Regulator in Diffuse Large B‐Cell Lymphoma
1个月前
已完结
Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer Immunotherapy
1个月前
已完结
mRNA-Based Cancer Vaccines: A Review of the Current Scenario and Future Prospects
5个月前
已完结
皖公网安备34019202002308
